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Case Report
Use of Ultrasound-Guided Platelet-Rich Plasma in
the Treatment of Carpometacarpal Osteoarthritis
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Abstract

Manuel Britto, MD

Introduction

GME Office

Osteoarthritis (OA) is the most common form of arthritis and can severely affect function
and quality of life. Platelet-rich plasma (PRP) is derived from a patient’s own blood and has
potential as an adjunct to treat OA. However, research has been limited for small joints such
as the carpometacarpal (CMC) joint.
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A 65-year-old Caucasian male complained of bilateral wrist and neck pain after a motor
vehicle accident. His initial exam noted swelling, tenderness and pain with movement at
the bilateral thumb CMC joints and anatomic snuffboxes. However, there was no strength,
range of motion or tactile deficits during examination.

Outcomes

He was found to have moderate to severe OA bilaterally in his left and right CMC joints
seen on computed tomography and magnetic resonance imaging. The patient was initially
treated with ultrasound (US)-guided steroid injections but did not experience significant
improvement. After careful discussion, the patient chose to undergo US-guided injection
of PRP into both joints. Follow-up at six weeks after PRP injection revealed that there was
functional improvement in both joints as well as objective improvement via the Mayo Wrist
Score survey.

Conclusion

US-guided PRP injection can be used as an alternative modality to treat OA of the CMC
joints when approaches such as conservative therapy and steroid injections have failed. PRP
has not been as well studied as other interventions such as corticosteroid injections, but it
may offer less long-term adverse effects and be considered a potential alternative or adjuvant to current treatment modalities.
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Background

The 2017 Global Burden of Disease Study
reported that osteoarthritis (OA) is the second largest contributor to the years lived with
disability among musculoskeletal disorders, accounting for around 7.1% of this burden, which
is a statistically significant increase from prior
reports.1 The incidence of OA increases with
age and gender (higher in women compared
to men).2 Population studies have found the
highest rates of symptomatic OA in the knee

(240 per 100,000 person-years) with intermediate rates for symptomatic hand OA (100 per
100,000 person-years).3 Goals of care with OA
management aim towards minimizing pain,
optimizing function and modifying the process
of joint damage. Intra-articular corticosteroid
injections have the potential for long term
damage with higher doses and complications
in patients with medical comorbidities.4 Therefore, exploration for other treatment modalities such as platelet-rich plasma (PRP) therapy
have been explored.
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Figure 1: A) X-ray of the left wrist showing moderate to severe arthritic changes in the base of the
thumb in the first CMC joint space, B) X-ray of the right wrist showing severe arthritic changes
present in the base of the thumb in the first CMC joint space.
Platelet-rich plasma is derived from autologous
blood with platelets being the main component. The mechanism of action is thought to
involve growth factors mediating the increase
of matrix synthesis and collagen production.5
This case report utilized the OrthoToolKit Modified Mayo Wrist score, which assesses pain
intensity, functional status, range of motion
and grip strength.6 Scores range from 0 to 25
for each component with a total score of 100;
higher scores indicate better wrist function.

Case Presentation

The patient is a 65-year-old obese Caucasian
male and former smoker who initially presented to the sports medicine clinic after injuring
his neck and wrists in a motor vehicle accident four weeks prior. His medical history was
significant for ulcerative colitis, hypertension,
osteoarthritis and occasional alcohol use. His
surgical history was significant for trigger finger release, carpal tunnel release and bilateral
knee replacement. During his initial visit, his
physical examination was notable for swelling,
tenderness and pain with movement at the bilateral thumb CMC joints and anatomic snuffboxes. However, the patient did not exhibit
strength, range of motion, or tactile deficits
during examination. An x-ray of the left hand
(Figure 1A) showed moderate to severe thumb
CMC osteoarthritis. An x-ray of the right hand
(Figure 1B) showed severe thumb CMC osteoarthritis, a possible non-displaced fracture of
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the scaphoid bone, and signs of scapholunate
dissociation. A magnetic resonance imaging
(MRI) scan of both wrists was ordered to rule
out a fracture of the scaphoid bone. He was
treated symptomatically with oral methylprednisolone and a thumb spica brace.
He returned two weeks later for follow-up,
complaining of persistent wrist pain despite
compliance with the thumb spica brace for his
right thumb. An MRI of the left wrist (Figure 2A) showed bone marrow edema in the
scaphoid bone, suspicious for a non-displaced
fracture, in addition to severe hypertrophic
changes in the first CMC joint. An MRI of the
right wrist (Figure 2B) showed severe changes
at the base of the thumb consistent with CMC
osteoarthritis as well as multiple erosions at
the wrist joint and metacarpal heads, suspicious for rheumatoid arthritis. An autoimmune
workup consisting of erythrocyte sedimentation rate, C-reactive protein, antinuclear
antibody and rheumatoid factor was ordered.
A computed tomogram (CT) was ordered and
the patient was started on meloxicam 15 mg
once a day.
Four weeks after the initial presentation, the
CT of the left wrist (Figure 3) revealed significant degenerative joint disease with worse
arthritic changes along the first CMC joint
space and no visible fracture. The autoimmune
workup was negative. The patient continued
to complain of bilateral thumb pain without

Britto et al. (2021) 2:4. https://doi.org/10.36518/2689-0216.1200

A

B

Figure 2: A) MRI T2 coronal of the left wrist showing severe hypertrophic change present in the
first CMC joint space, B) MRI T2 coronal of the right wrist showing severe hypertrophic changes
present in the first CMC joint space with superimposed erosive disease.
neurologic deficits. His options were discussed
and a plan was made to try steroid injections
in both CMC joints under ultrasound (US)
guidance to identify proximal aspects of the
metacarpal and interface with the carpal bone.
The outer plane injection into the bilateral
thumb CMC joints was performed containing
a mixture of 0.7 cc of 2% lidocaine and 0.7 cc of
betamethasone 4 mg. The 15 mg of meloxicam
once daily was also continued. He was scheduled for a four-week follow-up appointment.
During the third follow-up visit (eight weeks
after the initial appointment), he continued to
complain of bilateral pain at the thumb CMC
joints. He expressed interest in undergoing
a trial of PRP injections in both thumb CMC
joints. The mechanism of action, procedure,
risks and benefits were discussed with him at
length, and he consented to proceeding with
PRP, which was scheduled and performed
one week later. He was advised to discontin-

ue meloxicam, continue the use of the thumb
spica brace to protect and immobilize the affected joint, and apply cold compresses a few
times a day for 10-20 minutes to help decrease
post-injection pain and swelling.
Three weeks after the PRP injections, he reported minimal relief with worse pain in his
right wrist compared to his left. He denied any
functional limitations with respect to work and
activities of daily living. He scored +35 and +45
on his right and left wrists respectively on the
Mayo Wrist Score survey. The right wrist score
breakdown was +15 for moderate tolerable
pain, +20 for restricted employment, 0 points
for less than 30° range of motion and 0 points
for 0–25% grip strength. The left wrist score
breakdown was +15 for moderate tolerable
pain, +20 for restricted employment, +5 for
30°–60° range of motion and +5 for 25–50%
grip strength. Options of care were discussed
at this time, and he was advised to continue

Figure 3: CT of the left wrist showing arthritic changes along the first CMC joint space.
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wearing a thumb spica brace on both hands as
needed.
At his follow-up visit at six weeks post PRP
injections, he continued to have bilateral wrist
pain. Despite the persistent pain, his wrist
outcome survey scored improved to +75 and
+85 on his right and left wrists respectively. The
right wrist score breakdown was +15 for moderate tolerable pain, +25 for returned to regular
employment, +25 points for greater than 120°
range of motion and +10 points for 50–75% grip
strength. The left wrist score breakdown was
+20 for mild occasional pain, +25 for returned
to regular employment, +25 for greater than
120° range of motion and +15 for 75–99% grip
strength. The plan was to continue the rehabilitation protocol with strength exercises and
bracing as needed.
At the patient’s 12-week follow-up visit, post
PRP injections (21 weeks after initial appointment), he reported increasing pain in his right
thumb but his left thumb felt well. He was
given options for repeat PRP injections or an
evaluation with an orthopedic surgeon. He was
advised to continue his strengthening regimen while also using his thumb spica braces as
needed.

Discussion

The use of PRP injections for OA has been rapidly evolving. However, there is no consensus on
its efficacy yet. A 2016 systematic review of 13
trials examining the risks and benefits of PRP
in sports medicine showed no improvement
compared to standard intervention across a
variety of musculoskeletal tissues when assessing pain scores and physical activity/function.7 It is important to note this systematic
review was not specific to OA as it examined
the efficacy of PRP in a variety of musculoskeletal disorders such as tendinitis, fasciitis
and bursitis in addition to OA. There also exist
multiple studies reporting improvement in pain
scores and physical activity/function using PRP
in ligaments and tendons involving the ankle
and knee.8-10 Furthermore, a 2015 meta-analysis
of 10 trials assessing PRP injections for knee
OA, which encompassed 1,110 patients, revealed
statistically better outcomes in favor of PRP
based on pain reduction when compared to
hyaluronic acid and placebo injections.11 Lastly,
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a 2017 systematic review of 29 trials looking at
PRP for degenerative cartilage disease including the knee and hip, which encompassed
2,668 patients, concluded that there is clinical
evidence to support the benefit of PRP in the
treatment of knee and hip OA in regards to
pain and functionality when compared with
treatments including hyaluronic acid, exercise,
acetaminophen and saline injections.12
Of note, it has been reported in literature that
there may be a lack of significant long-term
improvement over a period of 12–18 months
with the use of steroid injections in the CMC
joint.13,14 Steroid injections may be helpful for
early stage thumb CMC arthritis, but additional
injections can lead to weakening of the joint.15
Furthermore, there have been adverse effects
documented with the use of corticosteroid
injection, which can be seen as soon as three
months, such as osteonecrosis, accelerated OA
progression, subchondral insufficiency fracture, complications of osteonecrosis, rapid joint
destruction and cartilage damage.16,17 Studies
examining PRP in the knee joint showed no major short-term (three months to one year) or
long-term (greater than one year) adverse effects other than minor injection site reactions
such as pain, bleeding, tenderness, swelling and
bruising at the injection site.18,19
Because the pathophysiology of OA is essentially the same regardless of joint size, PRP
should be effective in small joints like the CMC
joint of the hand as it is in large weight-bearing
joints like the knee. A search of current literature revealed a paucity of studies relating to
PRP injections in the small joints, such as the
hands, with a majority of literature published
around large joints, such as the hip and knee. At
this time there are no standardized approaches
to treating OA with PRP as there are different
protocols and platelet centrifugation processes.20,21

Conclusion

This case report details US-guided steroid
injection followed by US-guided PRP injection
in a 65-year-old male with bilateral CMC joint
osteoarthritis. He did not report any significant improvement after five weeks of steroid
injections. After the PRP injection, he seemed
to objectively improve, yet, subjectively, he did
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not feel his pain and functionality had returned
to baseline in the right CMC joint in light of
these findings. However, he was able to return
to work and daily living activities.

4.

The scope of this study was hindered by a lack
of baseline Mayo wrist scores prior to undergoing PRP and lack of long-term follow-up
beyond six weeks. Efforts to build upon this
study include obtaining imaging studies to look
at structural changes in the CMC joint. Further research is needed in order to establish a
standardized method for implementing PRP
therapy as there has been a paucity of research
in this area, specifically in small joints such as
CMC, and the use of US guidance and the protocol for extracting autologous platelets from a
patient’s blood.
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